Journal of Liver Cancer

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Young Youn Cho, Young Hwan Choi, Su Jong Yu, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon

J Liver Cancer. 2019;19(2):128-135. Published online September 30, 2019
DOI: https://doi.org/10.17998/jlc.19.2.128

Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Young Youn Cho, Young Hwan Choi, Su Jong Yu, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon

Journal of Liver Cancer. 2019;19(2):128-135

Link1

Link2 Link3

Exam 2: Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B

Clinical Gastroenterology and Hepatology. 2012;10(8):e68

Link1 Link2

Mo1501 Similar Transplant-Free Survival With Transarterial Chemoembolization (TACE) Versus Transarterial Radioembolization (TARE) in Patients With Hepatocellular Carcinoma

Divya Bhatt, Amitkumar Patel, Stacy Achdjian, Meera Ramanathan, Layth AL-Jashaami, Myunghan Choi, Anil B. Seetharam

Gastroenterology. 2016;150(4):S1132-S1133

Link1 Link2

Transarterial chemoembolization and renal failure in hepatocellular carcinoma patients: authors' reply

Chia-Yang Hsu, Teh-Ia Huo

Liver International. 2009;30(6):924-925

Link1 Link2

Nonresectable Hepatocellular Carcinoma: Long-term Toxicity in Patients Treated with Transarterial Chemoembolization—Single-Center Experience

T.G. Walker

Yearbook of Diagnostic Radiology. 2009;2009:212-214

Link1 Link2

Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B

Robert G. Gish, Margaret D. Clark, Steve D. Kane, Richard E. Shaw, Michael F. Mangahas, Sumbella Baqai

Clinical Gastroenterology and Hepatology. 2012;10(8):941-946

Link1 Link2

Hypothyroidism in patients with hepatocellular carcinoma treated by transarterial chemoembolization

Felix Flohr, Jan Harder, Jochen Seufert, Hubert E. Blum, Hans C. Spangenberg

Hepatology. 2008;47(6):2144-2144

Link1 Link2

A Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients

Guangshao Cao, Yuyan Liu, Lupeng Li, Xiaoyang Zhao, Ruiqing Liu, Jian Liu, Jianwen Liu, Huicun Cao

Cancer Management and Research. 2021;Volume 13:5373-5382

Link1 Link2

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study

Tao Ouyang, Junxia Liu, Chengyang Shi, Lisheng Zhu, Xiaopeng Guo

Journal of Hepatocellular Carcinoma. 2021;Volume 8:1459-1471

Link1 Link2

Reply to: “Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B”

George Papatheodoridis, Vana Sypsa, Pietro Lampertico

Journal of Hepatology. 2021;74(1):246-247

Link1 Link2